analyses. Some of the new synthesized compounds were assayed for their in vitro antibacterial activity against Gram-positive bacteria, Staphylococcus aureus and Staphylococcus epidermidis, Gram-negative bacteria, Escherichia coli and Klebsiella pneumonia and antifungal activity against Aspergillus fumigatus and Candida albicans. Most of the new compounds showed significant antibacterial and antifungal
已经开发了有效且简单的微波辅助合成并入
哒嗪部分的磺酰胺衍
生物。这些磺酰胺用于通过微波辐照技术与不同试剂的反应来制备新的
杂环化合物。根据FTIR,(1)H和(13)C-NMR,质谱技术和元素分析确定了新合成的化合物的结构。测定了一些新合成的化合物对革兰氏阳性菌,
金黄色葡萄球菌和表皮葡萄球菌,革兰氏阴性菌,大肠埃希菌和肺炎克雷伯菌的体外抗菌活性以及对烟曲霉和白色念珠菌的抗真菌活性。大多数新化合物显示出显着的抗菌和抗真菌活性。